Abstract
Generation time varies widely across organisms and is an important factor in the life cycle, life history and evolution of organisms. Although the doubling time (DT) has been estimated for many bacteria in the laboratory, it is nearly impossible to directly measure it in the natural environment. However, an estimate can be obtained by measuring the rate at which bacteria accumulate mutations per year in the wild and the rate at which they mutate per generation in the laboratory. If we assume the mutation rate per generation is the same in the wild and in the laboratory, and that all mutations in the wild are neutral, an assumption that we show is not very important, then an estimate of the DT can be obtained by dividing the latter by the former. We estimate the DT for five species of bacteria for which we have both an accumulation and a mutation rate estimate. We also infer the distribution of DTs across all bacteria from the distribution of the accumulation and mutation rates. Both analyses suggest that DTs for bacteria in the wild are substantially greater than those in the laboratory, that they vary by orders of magnitude between different species of bacteria and that a substantial fraction of bacteria double very slowly in the wild.
Keywords: generation time, mutation rates, bacteria
1. Introduction
The bacterium Escherichia coli can divide every 20 min in the laboratory under aerobic, nutrient-rich conditions. But how often does it divide in its natural environment in the gut, under anaerobic conditions where it probably spends much of its time close to starvation? And what do we make of a bacterium, such as Syntrophobacter fumaroxidans, which only doubles in the laboratory every 140 h [1]. Does this reflect a slow doubling time (DT) in the wild, or our inability to provide the conditions under which it can replicate rapidly?
Estimating the generation time is difficult for most bacteria in their natural environment and very few estimates are available. The DT for intestinal bacteria has been estimated in several mammals by assaying the quantity of bacteria in the gut and faeces. Assuming no cell death Gibbons & Kapsimalis [2] estimate the DT for all bacteria in the gut to be 48, 17 and 5.8 h in hamster, guinea pig and mouse, respectively. More recently Yang et al. [3] have shown that the DT of Pseudomonas aeruginosa is correlated to cellular ribosomal content in vitro and have used this to estimate the DT in vivo in a cystic fibrosis (CF) patient to be between 1.9 and 2.4 h.
Although there are very few estimates of the generation time in bacteria, this quantity is important for understanding bacterial population dynamics. Here we use an indirect method to estimate the DT that uses two sources of information. First, we can measure the rate at which a bacterial species accumulates mutations in its natural environment through time using temporarily sampled data [4], or concurrent samples from a population with a known date of origin. We refer to this quantity as the accumulation rate, to differentiate it from the mutation rate, and the substitution rate, the rate at which mutations spread through a species to fixation. If we assume that all mutations in the wild are neutral, an assumption that we show to be relatively unimportant, then the accumulation rate is an estimate of the mutation rate per year, uy. Second, we can estimate the rate of mutation per generation, ug, in the laboratory using a mutation accumulation experiment and whole-genome sequencing, or through fluctuation tests. If we assume that the mutation rate per generation is the same in the wild and in the laboratory, an assumption we discuss further below, then if we divide the accumulation rate per year in the wild by the mutation rate per generation in the laboratory, we can estimate the number of generations that the bacterium goes through in the wild and hence the DT (DT = 8760 × ug/uy, where 8760 is the number of hours per year).
2. Results
The accumulation rate in the wild and the mutation rate in the laboratory have been estimated for 34 and 26 bacterial species, respectively (electronic supplementary material, tables S1, S2); we only consider mutation rate estimates from mutation accumulation experiments, because estimates from fluctuation tests are subject to substantial sampling error and unknown bias, and we exclude estimates from hypermutable strains. For five species, E. coli, P. aeruginosa, Salmonella enterica, Staphylococcus aureus and Vibrio cholerae, we have both an accumulation and a mutation rate estimate and hence can estimate the DT. Among these five species we find our DT estimates vary from 1.1 h in V. cholerae to 25 h in S. enterica (table 1). In all cases the estimated DT in the wild is greater than that of the bacterium in the laboratory. For example, E. coli can double every 20 min in the laboratory but we estimate that it only doubles every 15 h in the wild.
Table 1.
species | accumulation rate per site per year | mutation rate per site per generation | DT (h) (s.e.) | laboratory DT (h) | ratio | AR ref. | MR ref. |
---|---|---|---|---|---|---|---|
Escherichia coli | 1.44 × 10−7 | 2.54 × 10−10 | 15 (7.7) | 0.33 | 45 | 1 | 6 |
Pseudomonas aeruginosa | 3.03 × 10−7 | 7.92 × 10−11 | 2.3 (0.77) | 0.5 | 4.6 | 2 | 7 |
Salmonella enterica | 2.50 × 10−7 | 7.00 × 10−10 | 25 (7.9) | 0.5 | 50 | 3 | 8 |
Staphylococcus aureus | 2.05 × 10−6 | 4.38 × 10−10 | 1.87 (0.98) | 0.4 | 4.7 | 4 | 9 |
Vibrio cholerae | 8.30 × 10−7 | 1.07 × 10−10 | 1.1 (0.26) | 0.66 | 1.7 | 5 | 10 |
In theory, it might be possible to estimate the DT in those bacteria for which we have either an accumulation or mutation rate estimate, but not both, by finding factors that correlate with either rate and using those factors to predict the rates. Unfortunately, we have been unable to find any factor that correlates sufficiently well to be usefully predictive. It has been suggested that the mutation rate is correlated to genome size in microbes [30] but, the current evidence for this correlation is very weak, and depends upon the estimate from Mesoplasma florum (r = −0.68, p < 0.001 with M. florum and r = −0.39, p = 0.053 without M. florum) (electronic supplementary material, figure S1) [31]. However, we can use the accumulation and mutation rate estimates to estimate the distribution of DTs across bacteria if we assume that there is no phylogenetic non-independence in the mutation and accumulation data, an assumption we address below. We can estimate the distribution of DTs by fitting distributions to the accumulation and mutation rate data, using maximum likelihood, and then dividing one distribution by the other. We assume that both variables are lognormally distributed, an assumption that is supported by Q–Q plots with the exception of the mutation rate per generation in M. florum, which is a clear outlier (figure 1). We repeated all our analyses with and without M. florum.
If the accumulation and mutation rate data are lognormally distributed then the distribution of DT is also lognormally distributed with a mean of loge(8760) + mg − my and a variance of vg + vy − 2Cov(g,y), where 8760 is the number of hours per year and mg, my, vg and vy are the mean and variance of the lognormal distributions fitted to the mutation (subscript g) and accumulation (subscript y) rates. Cov(g,y) is the covariance between the accumulation and mutation rates. We might expect that species with higher mutation rates also have higher accumulation rates, because the accumulation rate is expected to depend on the mutation rate, but the correlation between the two will depend upon how variable the DT and other factors, such as the strength of selection, are between bacteria. The observed correlation between the log accumulation rate and log mutation rate is 0.077, but there are only five data points, so the 95% confidence intervals on this estimate encompass almost all possible values (−0.86 to 0.89). We explore different levels of the correlation between the accumulation and mutation rates; it should be noted that Cov(g,y) can be expressed as Sqrt(vg vy) Corr(g,y) where Corr(g,y) is the correlation between the two variables.
The distribution of DTs in the wild inferred using our method is shown in figure 2. We infer the median DT to be 7.04 h, but there is considerable spread around this even when the accumulation and mutation rates are strongly correlated (figure 2a); as the correlation increases so the variance in DTs decreases, but the median remains unaffected. The analysis suggests that most bacteria have DTs of between 1 and 100 h but there are substantial numbers with DTs beyond these limits. For example, even if we assume that the correlation between the accumulation and mutation rate is 0.5 we infer that 10% of bacteria have a DT of faster than 1 h in the wild and 4.2% have a DT slower than 100 h in the wild. If we remove the M. florum mutation rate estimate from the analysis the median doubling is slightly lower at 6.16 h, but there is almost as much variation as when this bacterium is included; at a correlation is 0.5 we infer that 12% of bacteria have a DT faster than 1 h in the wild and 3.5% have a DT slower than 100 h.
To investigate how robust these conclusions are to statistical sampling, we bootstrapped the accumulation and mutation rate estimates, refit the lognormal distributions and reinferred the distribution of DT. The 95% confidence intervals for the median are quite broad at 3.4 to 14.2 h (3.1 to 11.3 h if we exclude M. florum). However, all bootstrapped distributions show substantial variation in the DT with a substantial fraction of bacteria with long DTs and also some with very short DTs (figure 3).
We have assumed that there is no phylogenetic inertia within the accumulation and mutation rate estimates. To test whether this is the case we constructed a phylogenetic tree using 16S rRNA sequences and applied the tests of Pagel [33] and Blomberg et al. [34]. Both the accumulation and mutation rate data show some evidence of phylogenetic signal. For the accumulation data, Pagel's λ = 0.68 (p = 0.001) and Blomberg et al.'s K = 0.0005 (p = 0.35); and for the mutation rate data Pagel's λ = 0.88 (p = 0.026) and Blomberg et al.'s K = 0.5 (p = 0.009). We also find some evidence that the data depart from a Brownian motion model using Pagel's test (i.e. λ is significantly less than one) for the accumulation data (p < 0.001) but not the mutation rate data (p = 0.094); i.e. the accumulation rates are more different than we would expect from their phylogeny and a Brownian motion model. A visual inspection of the data suggests that the phylogenetic signal is largely contributed by species that are closely related, rather than deeper phylogenetic levels (figure 4a,b) and species for which we have accumulation and mutation rate estimates are interspersed with one another on the phylogenetic tree (figure 4c). It, therefore, seems unlikely that phylogenetic inertia will influence our results.
It is of interest to compare the distribution of DTs in the wild to the distribution of laboratory DTs (figure 1). The distributions are different in two respects. First, the median laboratory DT of 3 h is less than half the median wild DT of 7.04 h (6.16 h without M. florum); the two are significantly different (p = 0.012 with M. florum and p = 0.016 without M. florum, inferred by bootstrapping each dataset and recalculating the medians). Second, many more bacteria are inferred to have long DTs in the wild than in the laboratory.
3. Discussion
The DT of most bacteria in their natural environment is not known. We have used estimates of the rate at which bacteria accumulate mutations in their natural environment and estimates of the rate at which they mutate in the laboratory to estimate the DT for several bacteria and infer the distribution of DTs across bacteria. We estimate that DT are generally longer in the wild than in the laboratory, but critically we also infer that DTs vary by several orders of magnitude between bacterial species and that many bacteria have very slow DTs in their natural environment.
The method, by which we have inferred the DT in the wild, makes three important assumptions. We assume that the mutation rate per generation is the same in the laboratory and in the wild. However, it seems likely that bacteria in the wild will have a higher mutation rate per generation than those in the laboratory for two reasons. First, bacteria in the wild are likely to be stressed and this can be expected to elevate the mutation rate [35–39]. Second, if we assume that DTs are longer in the wild than the laboratory then we expect the mutation rate per generation to be higher in the wild than in the laboratory because some mutational processes do not depend upon DNA replication. The relative contribution of replication dependent and independent mutational mechanisms to the overall mutation rate is unknown. Rates of substitution are higher in Firmicutes that do not undergo sporulation suggesting that replication is a source of mutations in this group of bacteria [40]. However, rates of mutation accumulation seem to be similar in latent versus active infections of Mycobacterium tuberculosis, suggesting that replication independent mutations might dominate in this bacterium [41,42].
The second major assumption is that the rate at which mutations accumulate in the wild is equal to the mutation rate per year; in effect, we are assuming that all mutations are effectively neutral, at least over the time frame in which they are assayed (or that some are inviable, but the same proportion are inviable in the wild and the laboratory). In those accumulation rate studies, in which they have been studied separately, non-synonymous mutations accumulate more slowly than synonymous mutations; relative rates vary from 0.13 to 0.8, with a mean of 0.57 (electronic supplementary material, table S3). There is no correlation between the time frame over which the estimate was made and the ratio of non-synonymous and synonymous accumulation rates (r = 0.2, p = 0.53). We did not attempt to control for selection because the relative rates of synonymous and non-synonymous accumulation are only available for a few species, and the relative rates vary between species. However, we can estimate the degree to which more selection against deleterious non-synonymous accumulations in the wild causes the DT to be underestimated as follows. The observed rate at which mutations accumulate in a bacterial lineage is
3.1 |
where α is the proportion of the genome that is non-coding and β is the proportion of mutations in protein coding sequence that are non-synonymous. δx is the proportion of mutations of class x (i is intergenic, s is synonymous and n is non-synonymous) that are effectively neutral. α and β are approximately 0.15 and 0.7, respectively, in our dataset. Although there is selection on synonymous codon use in many bacteria [43], selection appears to be weak [44] we, therefore, assume that δs = 1. This implies, from the rate at which non-synonymous mutations accumulate relative to synonymous mutations, that δn = 0.6. A recent analysis of intergenic regions in several species of bacteria has concluded that selection is weaker in intergenic regions than at non-synonymous sites; we, therefore, assume that δi = 0.8 [45]. Using these estimates suggests that selection leads us to underestimate the true mutation rate per year in the wild by approximately 27%; this in turn means we have over-estimated the DT by approximately 37%, a relatively small effect. To investigate how sensitive this estimate is to the parameters in equation 1, we varied each of them in turn (electronic supplementary material, table S4). We find that the observed mutation rate is most sensitive to selection on synonymous codon use, because if there is selection on synonymous codon use this also affects our estimates of selection at non-synonymous sites and in intergenic. For example, if selection on synonymous codon use depressed the synonymous accumulation rate by 0.5 this would lead to an underestimate of the mutation rate of 63%, which would in turn have led to a 2.7-fold over-estimate of the DT.
Finally, although each study attempted to remove single nucleotide polymorphisms (SNPs) that had arisen by recombination, it is possible that some are still present in the data. Recombinant SNPs can have two effects. First, if they have recombined from outside the clade, they inflate the accumulation rate estimate and hence lead to an underestimate of the DT. Second, if there is recombination within a clade, they affect the phylogeny and potentially lead to the root of the tree being estimated as younger than it should be. This will lead to an overestimate of the DT.
It is important to appreciate that our method estimates an average DT within a particular environment that the bacteria were sampled from. The bacterium may go through periods of quiescence interspersed with periods of growth.
Despite the assumptions we have made in our method, our estimate of the DT of Pseudomonas aruginosa of 2.3 h in a CF patient is very similar to that independently estimated using the ribosomal content of cells of between 1.9 and 2.4 h [3]. There is also independent evidence that there are some bacteria that divide slowly in their natural environment. The aphid symbiont Buchnera aphidicola is estimated to double every 175–292 h in its host [46,47], and Mycobacterium leprae doubles every 300–600 h on mouse footpads [48–50], not its natural environment, but one that is probably similar to the human skin. Furthermore, in a recent selection experiment, Avrani et al. [51] found that several E. coli populations, which were starved of resources, accumulated mutations in the core RNA polymerase gene. These mutations caused these strains to divide more slowly than unmutated strains when resources were plentiful. Interestingly these same mutations are found at high frequency in unculturable bacteria, suggesting that there is a class of slow growing bacteria in the environment that are adapted to starvation.
Korem et al. [52] have recently proposed a general method by which the DT can be potentially estimated. They note that actively replicating bacterial cells have two or more copies of the chromosome near the origin of replication but only one copy near the terminus, if cell division occurs rapidly after the completion of DNA replication. Using next-generation sequencing, they show that it is possible to assay this signal and that the ratio of sequencing depth near the origin and terminus is correlated to bacterial growth rates in vivo. Brown et al. [53] have extended the method to bacteria without a reference genome and/or those without a known origin and terminus of replication. In principle, these measures of cells performing DNA replication could be used to estimate the DT of bacteria in the wild. However, it is unclear how or whether the methods can be calibrated. Both Korem et al. (2015) and Brown et al. (2016) find that their replication measures have a median of approximately 1.3 across bacteria in the human gut. However, a value of 1.3 translates into different relative and absolute values of the DT in the two studies. Brown et al. [53] show that their measure of replication, iRep, is highly correlated to Korem et al.'s [52] measure, PTR, for data from Lactobacillus gasseri; the equation relating the two statistics is iRep = −0.75 + 2 PTR. Hence, when PTR = 1.3, iRep = 1.85 and when iRep = 1.3, PTR = 1.03. The two methods are not consistent. They also yield very different estimates for the absolute DT. Korem et al. [52] show that PTR is highly correlated to the growth rate of E. coli grown in a chemostat. If we assume that the relationship between PTR and growth rate is the same across bacteria in vivo and in vitro, then this implies that the median DT for the human microbiome is approximately 2.5 h. By contrast, Brown et al. [53] estimate the growth rate of Klebsiella oxytoca to be 19.7 h in a new-born baby using faecal counts and find that this population has an iRep value of approximately 1.77. This value is greater than the vast majority of bacteria in the human microbiome and bacteria in the Candidate Phyla Radiation, suggesting that most bacteria in these two communities replicate very slowly. These discrepancies between the two methods suggest that it may not be easy to calibrate the PTR and iRep methods to yield estimates of the DT across bacteria.
Finally, how should we interpret our results for the five focal species in the context of what is known of their ecology? Vibrio cholerae displays the shortest DT of 1.1 h. Vibrio species are ubiquitous in estuarine and marine environments [54]. They are known to have very short generation times in culture, the shortest being Vibrio natriegens of just 9.8 min [55]. In the wild they can exploit a wide range of carbon and energy sources, and as such have been termed ‘opportunitrophs’ [56]. Natural Vibrio communities do not grow at an accelerated rate continuously, but can exist for long periods in a semi-dormant state punctuated by rapid pulses of high growth rates [57], or blooms [58], when conditions are favourable. It has also been argued that the unusual division of Vibrio genomes into two chromosomes facilitates more rapid growth [59]. By pointing to a very short DT in V. cholerae, our analysis is, therefore, consistent with what is known of the ecology of this species.
Staphylococcus aureus is predominantly found on animals and humans and inhabits various body parts, including the skin and upper respiratory tract [60]. It can cause infection of the skin and soft tissue as well as bacteraemia [61]. Staphylococcus aureus exhibits a range of modes of growth, some of which may to allow it to survive stress and antimicrobials while in its host. For instance, small subpopulations can adopt a slow-growing, quasi-dormant lifestyle, either in a multicellular biofilm or as small colony variants (SCVs) or persister cells [62]. Our short DT of 1.8 h suggests this is not the typical state for S. aureus in the wild, which is not surprising considering the incidence of SCVs in clinical samples is fairly low, between 1 and 30% [63].
Pseudomonas aeruginosa can inhabit a wide variety of environments, including soil, water, plants and animals. Like our other focal species, it is an opportunistic pathogen and can also infect humans, especially those with compromised immune systems, such as patients with CF. In this context infection is chronic. Parallel evolution, the differential regulation of genes which allow it to evade the host immune system and resist antibiotic treatment during infection [64], and evidence of positive selection [65] suggests P. aeruginosa can adapt to the lungs of individuals with CF for its long-term survival. It is known to actively grow in sputum [3], where it uses the available nutrition which supports its growth to high population densities [66]. Its ability to adapt and actively grow in the CF sputum is consistent with its relatively short DT of 2.3 h, especially considering this is the environment in which the accumulation rate was measured and matches that estimated by Yang et al. [3].
Escherichia coli and S. enterica primarily reside in the lower intestine of humans and animals, but can also survive in the environment. Although E. coli is commonly recovered from environmental samples, it is not thought able to grow or survive for prolonged periods outside of the guts of warm blooded animals, except in tropical regions where conditions are more favourable [67], although some phylogenetically distinct strains appear to reproduce and survive well in the environment [68]. In contrast, Salmonella is also an enteric colonizer of cold-blooded animals, in particular reptiles, is better adapted than E. coli at surviving and growing in environmental niches. For example, Salmonella can survive and grow for at least a year in soil [69], whereas E. coli can survive for only a few days [70]. Although these secondary niches may play a greater role in Salmonella than in E. coli, it remains the case the growth rates in the environment will be much lower than those in a gut. Therefore, the increased tenacity of Salmonella in non-host environments compared to E. coli might help to explain the slower DT in this species.
In summary, the availability of accumulation and mutation rate estimates allows us to infer the DT for bacteria in the wild, and the distribution of wild DTs across bacterial species. These DT estimates are likely to be underestimates because the mutation rate per generation is expected to be higher in the wild than in the laboratory, and some mutations are not generated by DNA replication. Our analysis, therefore, suggests that DTs in the wild are typically longer than those in the laboratory, that they vary considerably between bacterial species and that a substantial proportion of species have very long DTs in the wild.
4. Material and methods
We compiled estimates of the accumulation and mutation rate of bacteria from the literature. We only used mutation rate estimates that came from a mutation accumulation experiment with whole-genome sequencing. If we had multiple estimates of the mutation rate we summed the number of mutations across the mutation accumulation experiments and divided this by the product of the genome size and the number of generations that were assayed. We averaged the accumulation rate estimates where we had multiple estimates from the same species. We recalculated the accumulation rates in two cases in which the number of accumulated mutations had been divided by an incorrect number of years: E. coli [5] and Helicobacter pylori [71]. For E. coli, we reestimated the accumulation rate using BEAST by constructing sequences of the SNPs reported in the paper and the isolation dates. For, Helicobacter pylori the 3-year and 16-year strains appear to form a clade to the exclusion of the 0-year strain because they share some differences from the 0-year strain. If the number of substitutions that have accumulated between the common ancestor of the 3-year and 16-year strain and each of the two strains are S3 and S16, respectively, then the rate of accumulation can be estimated as (S16 − S3)/(13 years × genome size). For the isolates NQ1707 and NQ4060 we have estimated the accumulation rate to be 5 × 10−6 and for NQ1671 and NQ4191 5.9 × 10−6. We excluded some accumulation rate estimates for a variety of reasons. We only considered accumulation rates sampled over an historical time frame of at most 1500 years. Most of our estimates of the accumulation rate are for all sites in the genome, so we excluded cases in which only the synonymous accumulation rate was given. We also excluded accumulation rates from hypermutable strains. Accumulation and mutation rate estimates used in the analysis are given in electronic supplementary material, tables S1 and S2, respectively.
The estimate of the standard error associated with our estimate of the DT was obtained using the standard formula for the variance of a ratio: V(x/y) = (M(x)/M(y))2(V(x)/M(x)2 + V(y)/M(y)2) where M and V are the mean and variance of x and y. The variance for the accumulation rate was either the variance between multiple estimates of the accumulation rate if they were available, or the variance associated with the estimate if there was only a single estimate. The variance associated with the mutation rate was derived by assuming that the number of mutations was Poisson distributed.
We fit lognormal distributions to the accumulation and mutation rate data by taking the loge of the values and then fitting a normal distribution by maximum likelihood using the FindDistributionParameters in Mathematica. Normal Q–Q plots for the accumulation and mutation rate data were produced using the qqnorm function in R version 1.0.143. In fitting these distributions, we have not taken into account the sampling error associated with the accumulation and mutation rate estimates. However, these sampling errors are small compared to the variance between species: for the accumulation rates the variance between species is 3.9 × 10−11 and the average error variance is an order of magnitude smaller at 3.6 × 10−12; for the mutation rate data, the variance between species is 7.5 × 10−18 and the average variance associated with sampling is more than two orders of magnitude smaller at 1.8 × 10−20. Note that we cannot perform these comparisons of variances on a log-scale because we do not have variance estimates for the log accumulation and mutation rates.
To estimate phylogenetic signal in the accumulation and mutation rates we generated phylogenetic trees for each set of species in the two datasets. 16S rRNA sequences were downloaded from the NCBI genome database (https://www.ncbi.nlm.nih.gov/genome/) and aligned using MUSCLE [72] performed in Geneious version 10.0.9 (http://www.geneious.com, Kearse et al. [73]). From these alignments, maximum-likelihood trees were constructed in RAxML [74] and integrated into the tests of Pagel [33] and Blomberg et al. [34] to the log10 (accumulation rates) and log10 (mutation rates) implemented in the phylosig function in the R package phytools v.0.6 [75]. For the mutation rate dataset two species were excluded because of erroneous positioning on the phylogeny. See electronic supplementary material, figure S2A,B for details.
Supplementary Material
Supplementary Material
Acknowledgements
We are very grateful to Michael Lynch for sharing his mutation rate estimates prior to publication.
Data accessibility
All relevant data for this work are available as electronic supplementary material accompanying this article.
Authors' contributions
All authors were involved in conceptualizing the work. B.G. and A.E.W. wrote the manuscript with support from D.J.W. and E.F. B.G. and A.E.W. carried out data collection and analysis. All authors provided critical feedback and shaped the research, analysis and manuscript.
Competing interests
The authors declare that they have no competing interests.
Funding
D.J.W. is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (grant no. 101237/Z/13/Z).
References
- 1.Harmsen HJM, van Kuijk BLM, Plugge CM, Akkermans ADL, De Vos WM, Stams AJM. 1998. Syntrophobacter furnaroxidans sp. nov., a syntrophic propionate-degrading sulfate-reducing bacterium. Int. J. Syst. Bacteriol. 48, 1383–1388. ( 10.1099/00207713-48-4-1383) [DOI] [PubMed] [Google Scholar]
- 2.Gibbons RJ, Kapsimalis B. 1967. Estimates of the overall rate of growth of the intestinal microflora of hamsters, guinea pigs, and mice. J. Bacteriol. 93, 510–512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Yang L, Haagensen JAJ, Jelsbak L, Johansen HK, Sternberg C, Høiby N, Molin S. 2008. In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J. Bacteriol. 190, 2767–2776. ( 10.1128/JB.01581-07) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Drummond AJ, Pybus OG, Rambaut A, Forsberg R, Rodrigo AG. 2003. Measurably evolving populations. Trends Ecol. Evol. 18, 481–488. ( 10.1016/S0169-5347(03)00216-7) [DOI] [Google Scholar]
- 5.Reeves PR, et al. 2011. Rates of mutation and host transmission for an Escherichia coli clone over 3 years. PLoS ONE 6, e26907 ( 10.1371/journal.pone.0026907) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Markussen T, Marvig RL. 2014. Environmental heterogeneity drives within-host diversification and evolution of Pseudomonas aeruginosa. MBio 5, e01592-14 ( 10.1128/mBio.01592-14.Editor) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Marvig RL, Johansen HK, Molin S, Jelsbak L. 2013. Genome analysis of a transmissible lineage of Pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLoS Genet. 9, e1003741 ( 10.1371/journal.pgen.1003741) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Duchêne S, Holt KE, Weill F-X, Le Hello S, Hawkey J, Edwards DJ, Fourment M, Holmes EC. 2016. Genome-scale rates of evolutionary change in bacteria. Microb. Genomics 2, e000094 ( 10.1101/069492) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Zhou Z, McCann A, Weill F-X, Blin C, Nair S, Wain J, Dougan G, Achtman M. 2014. Transient Darwinian selection in Salmonella enterica serovar Paratyphi A during 450 years of global spread of enteric fever. Proc. Natl Acad. Sci. USA 111, 12 199–12 204. ( 10.1073/pnas.1411012111) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Okoro CK, et al. 2012. Intracontinental spread of human invasive Salmonella typhimurium pathovariants in sub-Saharan Africa. Nat. Genet. 44, 1215–1221. ( 10.1038/ng.2423) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hawkey J, Edwards DJ, Dimovski K, Hiley L, Billman-Jacobe H, Hogg G, Holt KE. 2013. Evidence of microevolution of Salmonella typhimurium during a series of egg-associated outbreaks linked to a single chicken farm. BMC Genomics 14, 800 ( 10.1186/1471-2164-14-800) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Mather AE. 2013. Distinguishable epidemics of multidrug-resistant Salmonella typhimurium DT104 in different hosts. Science 341, 1514–1518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Stinear TP, Holt KE, Chua K, Stepnell J, Tuck KL, Coombs G, Harrison PF, Seemann T, Howden BP. 2014. Adaptive change inferred from genomic population analysis of the ST93 epidemic clone of community-associated methicillin-resistant Staphylococcus aureus. Genome Biol. Evol. 6, 366–378. ( 10.1093/gbe/evu022) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Baines SL, et al. 2015. Convergent adaptation in the dominant global hospital clone ST239 of methicillin-resistant Staphylococcus aureus. MBio 6, e00080-15 ( 10.1128/mBio.00080-15) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Ward MJ, Gibbons CL, McAdam PR, van Bunnik BAD, Girvan EK, Edwards GF, Fitzgerald JR, Woolhouse MEJ. 2014. Time-scaled evolutionary analysis of the transmission and antibiotic resistance dynamics of Staphylococcus aureus clonal complex 398. Appl. Environ. Microbiol. 80, 7275–7282. ( 10.1128/AEM.01777-14) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Holden MTG, et al. 2013. A genomic portrait of the emerfences, evolution, and global spread of methicillin-resistant Staphylococcus aureus. Genome Res. 23, 653–664. ( 10.1101/gr.147710.112.Freely) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Uhlemann A-C, Dordel J, Knox JR, Raven KE, Parkhill J, Holden MTG, Peacock SJ, Lowy FD. 2014. Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community. Proc. Natl Acad. Sci. USA 111, 6738–6743. ( 10.1073/pnas.1401006111) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Alam MT, Read TD, Petit RA, Boyle-Vavra S, Miller LG, Eells SJ, Daum RS, David MZ. 2015. Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing. MBio 6, e00054-15. ( 10.1128/mBio.00054-15) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Smyth DS, McDougal LK, Gran FW, Manoharan A, Enright MC, Song JH, De Lencastre H, Robinson DA. 2010. Population structure of a hybrid clonal group of methicillin-resistant Staphylococcus aureus, ST239-MRSA-III. PLoS ONE 5, e8582 ( 10.1371/journal.pone.0008582) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Harris SR, et al. 2010. Evolution of MRSA during hospital transmission and intercontinental spread. Science. 327, 469–474. ( 10.1126/science.1182395) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Gray RR, Tatem AJ, Johnson JA, Alekseyenko AV, Pybus OG, Suchard MA, Salemi M. 2011. Testing spatiotemporal hypothesis of bacterial evolution using methicillin-resistant Staphylococcus aureus ST239 genome-wide data within a Bayesian framework. Mol. Biol. Evol. 28, 1593–1603. ( 10.1093/molbev/msq319) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Nübel U, et al. 2010. A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus. PLoS Pathog. 6, e1000855 ( 10.1371/journal.ppat.1000855) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Young BC, et al. 2012. Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. Proc. Natl Acad. Sci. USA 109, 4550–4555. ( 10.1073/pnas.1113219109) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Mutreja A, et al. 2011. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature 477, 462–465. ( 10.1038/nature10392) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Lee H, Popodi E, Tang H, Foster PL. 2012. PNAS Plus: Rate and molecular spectrum of spontaneous mutations in the bacterium Escherichia coli as determined by whole-genome sequencing. Proc. Natl Acad. Sci. USA 109, E2774–E2783. ( 10.1073/pnas.1210309109) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Dettman JR, Sztepanacz JL, Kassen R. 2016. The properties of spontaneous mutations in the opportunistic pathogen Pseudomonas aeruginosa. BMC Genomics 17, 1–14. ( 10.1186/s12864-015-2244-3) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Lind PA, Andersson DI. 2008. Whole-genome mutational biases in bacteria. Proc. Natl Acad. Sci. USA 105, 17 878–17 883. ( 10.1073/pnas.0804445105) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Long H, et al. 2018. Evolutionary determinants of genome-wide nucleotide composition. Nat. Ecol. Evol. 2, 1–4. ( 10.1038/s41559-017-0425-y) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Sung W, Ackerman MS, Miller SF, Doak TG, Lynch M. 2012. Drift-barrier hypothesis and mutation-rate evolution. Proc. Natl Acad. Sci. USA 109, 18 488–18 492. ( 10.1073/pnas.1216223109) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Drake JW. 1991. A constant rate of spontaneous mutation in DNA-based microbes. Proc. Natl Acad. Sci. USA 88, 7160–7164. ( 10.1073/pnas.88.16.7160) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Lynch M, Ackerman MS, Gout J, Long H, Sung W, Thomas WK, Foster PL. 2016. Genetic drift, selection and the evolution of the mutation rate. Nat. Publ. Gr. 17, 704–714. ( 10.1038/nrg.2016.104) [DOI] [PubMed] [Google Scholar]
- 32.Vieira-Silva S, Rocha EPC. 2010. The systemic imprint of growth and its uses in ecological (meta)genomics. PLoS Genet. 6, e1000808 ( 10.1371/journal.pgen.1000808) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Pagel M. 1999. Inferring the historical patterns of biological evolution. Nature 401, 877–884. ( 10.1038/44766) [DOI] [PubMed] [Google Scholar]
- 34.Blomberg SP, Garland T, Ives AR. 2003. Testing for phylogenetic signal in comparative data: behavioral traits are more labile. Evolution 57, 717–745. ( 10.1111/j.0014-3820.2003.tb00285.x) [DOI] [PubMed] [Google Scholar]
- 35.Bjedov I, Tenaillon O, Gerard B, Souza V, Denamur E, Radman M, Francois T, Matic I. 2003. Stress-induced mutagenesis in bacteria. Science 300, 1404–1409. [DOI] [PubMed] [Google Scholar]
- 36.Galhardo RS, Hastings PJ, Rosenberg SM.. 2007. Mutation as a stress response and the regulation of evolvability. Crit. Rev. Biochem. Mol. Biol. 42, 399-435. ( 10.1080/10409230701648502) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Foster PL. 2007. Stress-induced mutagenesis in bacteria. Crit. Rev. Biochem. Mol. Biol. 42, 373–397. ( 10.1080/10409230701648494) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Maclean RC, Torres-barceló C, Moxon R. 2013. Evaluating evolutionary models of stress-induced mutagenesis in bacteria. Nat. Rev. Genet. 14, 221–227. ( 10.1038/nrg3415) [DOI] [PubMed] [Google Scholar]
- 39.Shewaramani S, Finn TJ, Leahy SC, Kassen R, Rainey B, Moon CD. 2017. Anaerobically grown Escherichia coli has an enhanced mutation rate and distinct mutational spectra. PLoS Genet. 13, 1–22. ( 10.1371/journal.pgen.1006570) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Weller C, Wu M. 2015. A generation-time effect on the rate of molecular evolution in bacteria. Evolution. 69, 643–652. ( 10.1111/evo.12597) [DOI] [PubMed] [Google Scholar]
- 41.Ford CB, et al. 2011. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat. Genet. 43, 482–486. ( 10.1038/ng.811) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Lillebaek T, Norman A, Rasmussen EM, Marvig RL, Folkvardsen DB, Andersen ÅB, Jelsbak L. 2016. Substantial molecular evolution and mutation rates in prolonged latent Mycobacterium tuberculosis infection in humans. Int. J. Med. Microbiol. 306, 580–585. ( 10.1016/j.ijmm.2016.05.017) [DOI] [PubMed] [Google Scholar]
- 43.Hershberg R, Petrov DA. 2008. Selection on codon bias. Annu. Rev. Genet. 42, 287–299. ( 10.1146/annurev.genet.42.110807.091442) [DOI] [PubMed] [Google Scholar]
- 44.Sharp PM, Bailes E, Grocock RJ, Peden JF, Sockett RE. 2005. Variation in the strength of selected codon usage bias among bacteria. Nucleic Acids Res. 33, 1141–1153. ( 10.1093/nar/gki242) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Thorpe HA, Bayliss SC, Hurst LD, Feil EJ. 2017. Comparative analyses of selection operating on non-translated intergenic regions of diverse bacterial species. Genetics 206, 363–376. ( 10.1534/genetics.116.195784) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Ochman H, Elwyn S, Moran NA. 1999. Calibrating bacterial evolution. Proc. Natl Acad. Sci. USA 96, 12 638–12 643. ( 10.1073/pnas.96.22.12638) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Clark MA, Moran NA, Baumann P. 1999. Sequence evolution in bacterial endosymbionts having extreme base compositions. Mol. Biol. Evol. 16, 1586–1598. ( 10.1093/oxfordjournals.molbev.a026071) [DOI] [PubMed] [Google Scholar]
- 48.Shepard CC. 1960. The experimental disease that follows the injection of human leprosy bacilli into foot-pads of mice. J. Exp. Med. 112, 445–454. ( 10.1016/j.infsof.2008.09.005) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Rees RJ. 1964. Limited multiplication of acid-fast bacilli in the foot-pads of mice inoculated with Mycobacterium leprae. Br. J. Exp. Pathol. 45, 207–218. [PMC free article] [PubMed] [Google Scholar]
- 50.Levy L. 1976. Bactericidal action of dapsone against Mycobacterium leprae in mice. Antimicrob. Agents Chemother. 9, 614–617. ( 10.1128/AAC.9.4.614) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Avrani S, Bolotin E, Katz S, Hershberg R. 2017. Rapid genetic adaptation during the first four months of survival under resource exhaustion. Mol. Biol. Evol. 34, 1758–1769. ( 10.1093/molbev/msx118) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Korem T, et al. 2015. Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples. Science 349, 1101–1106. ( 10.1126/science.aac4812) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Brown CT, Olm MR, Thomas BC, Banfield JF. 2016. Measurement of bacterial replication rates in microbial communities. Nat. Biotechnol. 34, 1256–1263. ( 10.1038/nbt.3704) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Reidl J, Klose KE. 2002. Vibrio cholerae and cholera: out of the water and into the host. FEMS Microbiol. Rev. 26, 125–139. ( 10.1111/j.1574-6976.2002.tb00605.x) [DOI] [PubMed] [Google Scholar]
- 55.ER G. 1961. Pseudomonas natriegens, a marine bacterium with a generation time of less than 10 min. J. Bacteriol. 83, 736–737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Polz MF, Hunt DE, Preheim SP, Weinreich DM. 2006. Patterns and mechanisms of genetic and phenotypic differentiation in marine microbes. Phil. Trans. R. Soc. B 361, 2009–2021. ( 10.1098/rstb.2006.1928) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Blokesch M, Schoolnik GK. 2008. The extracellular nuclease Dns and its role in natural transformation of Vibrio cholerae. J. Bacteriol. 190, 7232–7240. ( 10.1128/JB.00959-08) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Takemura AF, Chien DM, Polz MF. 2014. Associations and dynamics of Vibrionaceae in the environment, from the genus to the population level. Front. Microbiol. 5, 1–26. ( 10.3389/fmicb.2014.00038) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Yamaichi Y, Iida T, Park KS, Yamamoto K, Honda T. 1999. Physical and genetic map of the genome of Vibrio parahaemolyticus: presence of two chromosomes in Vibrio species. Mol. Microbiol. 31, 1513-1521. ( 10.1046/j.1365-2958.1999.01296.x) [DOI] [PubMed] [Google Scholar]
- 60.Schenck LP, Surette MG, Bowdish DME. 2016. Composition and immunological significance of the upper respiratory tract microbiota. FEBS Lett. 590, 3705–3720. ( 10.1002/1873-3468.12455) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.John JF. 2004. Staphylococcal infection: emerging clinical syndromes. In Staphylococcus aureus (eds DAA Ala'Aldeen, K Hiramatsu), pp. 1–30. Chichester, UK: Horwood Publishing Limited. [Google Scholar]
- 62.Bui LMG, Conlon BP, Kidd SP. 2017. Antibiotic tolerance and the alternative lifestyles of Staphylococcus aureus. Essays Biochem. 61, 71–79. ( 10.1042/EBC20160061) [DOI] [PubMed] [Google Scholar]
- 63.Proctor RA, von Eiff C, Kahl BC, Becker K, McNamara P, Herrmann M, Peters G. 2006. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 4, 295–305. ( 10.1038/nrmicro1384) [DOI] [PubMed] [Google Scholar]
- 64.Huse HK, Kwon T, Zlosnik JEA, Speert DP, Marcotte EM, Whiteley M. 2010. Parallel evolution in Pseudomonas aeruginosa over 39 000 generations in vivo. MBio 1, e00199-10 ( 10.1128/mBio.00199-10.Editor) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Smith EE, et al. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl Acad. Sci. USA 103, 8487–8492. ( 10.1073/pnas.0602138103) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Palmer KL, Mashburn LM, Singh PK, Whiteley M. 2005. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J. Bacteriol. 187, 5267–5277. ( 10.1128/JB.187.15.5267) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Winfiel MD, Groisman EA. 2003. Role of nonhost enviroments in the lifestyles of Salmonella and E. coli. Appl. Environ. Mcrobiol. 69, 3687–3694. ( 10.1128/AEM.69.7.3687) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Oh S, Buddenborg S, Yoder-Himes DR, Tiedje JM, Konstantinidis KT. 2012. Genomic diversity of Escherichia isolates from diverse habitats. PLoS ONE 7, e47005 ( 10.1371/journal.pone.0047005) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Davies RH, Wray C.. 1996. Seasonal variations in the isolation of Salmonella typhimurium, Salmonella enteritidis, Bacillus cereus and Clostridium perfringens from environmental samples. Zentralbl. Veterinarmed. B 43, 119–127. ( 10.1111/j.1439-0442.1996.tb00435.x) [DOI] [PubMed] [Google Scholar]
- 70.Bogosian G, Sammons L. 1996. Death of the Escherichia coli K-12 strain W3110 in soil and water. Appl. Environ. Microbiol. 62, 4114–4120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Kennemann L, et al. 2011. Helicobacter pylori genome evolution during human infection. Proc. Natl Acad. Sci. USA 108, 5033–5038. ( 10.1073/pnas.1018444108) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Edgar RC. 2004. MUSCLE: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792–1797. ( 10.1093/nar/gkh340) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Kearse M, et al. 2012. Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28, 1647–1649. ( 10.1093/bioinformatics/bts199) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Stamatakis A. 2014. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 30, 1312–1313. ( 10.1093/bioinformatics/btu033) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Revell LJ. 2012. phytools: An R package for phylogenetic comparative biology (and other things). Methods Ecol. Evol. 3, 217–223. ( 10.1111/j.2041-210X.2011.00169.x) [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data for this work are available as electronic supplementary material accompanying this article.